Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-26 Sale |
2023-01-27 4:44 pm |
Metacrine Inc. | MTCR | York Michael Chief Business Officer |
107,054 | $0.4141 | $44,331 | 103,499 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-27 Option Award |
2022-03-01 4:55 pm |
N/A 2032-02-26 |
Metacrine Inc. | MTCR | York Michael Chief Business Officer |
210,553 | $0 | 421,106 (Direct) |
View |
Ownership |
2022-02-24 4:52 pm |
N/A 2031-11-30 |
Metacrine Inc. | MTCR | York Michael Chief Business Officer |
0 | $0 | 235,000 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:10 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development |
2,897 | $2.8 | 7,059 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:52 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development |
36,000 | $0 | 36,000 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:40 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development |
2,662 | $3 | 4,162 (Direct) |
View |